Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 31, 2011

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Recurrent Uterine Corpus SarcomaUterine Carcinosarcoma
Interventions
DRUG

Pazopanib Hydrochloride

Given PO

Trial Locations (41)

10065

Memorial Sloan-Kettering Cancer Center, New York

19001

Abington Memorial Hospital, Abington

20010

MedStar Washington Hospital Center, Washington D.C.

21237

MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore

27599

UNC Lineberger Comprehensive Cancer Center, Chapel Hill

27710

Duke University Medical Center, Durham

28203

Carolinas Medical Center/Levine Cancer Institute, Charlotte

28204

Novant Health Presbyterian Medical Center, Charlotte

32803

Florida Hospital Orlando, Orlando

43214

Riverside Methodist Hospital, Columbus

44060

Lake University Ireland Cancer Center, Mentor

44106

Case Western Reserve University, Cleveland

44109

MetroHealth Medical Center, Cleveland

46202

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis

46260

Saint Vincent Oncology Center, Indianapolis

48060

Saint Joseph Mercy Port Huron, Port Huron

48093

Saint John Macomb-Oakland Hospital, Warren

48106

Michigan Cancer Research Consortium CCOP, Ann Arbor

48124

Oakwood Hospital and Medical Center, Dearborn

48154

Saint Mary Mercy Hospital, Livonia

48236

Saint John Hospital and Medical Center, Detroit

48341

Saint Joseph Mercy Oakland, Pontiac

48439

Genesys Regional Medical Center, Grand Blanc

48502

Hurley Medical Center, Flint

48532

Genesys Regional Medical Center-West Flint Campus, Flint

48601

Saint Mary's of Michigan, Saginaw

48912

Sparrow Hospital, Lansing

49201

Allegiance Health, Jackson

60521

Sudarshan K Sharma MD Limted-Gynecologic Oncology, Hinsdale

60637

University of Chicago Comprehensive Cancer Center, Chicago

65804

Cancer Research for the Ozarks NCORP, Springfield

65807

CoxHealth South Hospital, Springfield

68114

Nebraska Methodist Hospital, Omaha

73104

University of Oklahoma Health Sciences Center, Oklahoma City

74146

Oklahoma Cancer Specialists and Research Institute-Tulsa, Tulsa

80045

University of Colorado Cancer Center - Anschutz Cancer Pavilion, Aurora

06105

Smilow Cancer Hospital Care Center at Saint Francis, Hartford

06050

The Hospital of Central Connecticut, New Britain

48106-0995

Saint Joseph Mercy Hospital, Ann Arbor

08103

Cooper Hospital University Medical Center, Camden

02905

Women and Infants Hospital, Providence

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

NRG Oncology

OTHER

lead

National Cancer Institute (NCI)

NIH